NEW YORK (GenomeWeb News) – A patent infringement suit filed a year ago by Beckman Coulter and Orchid Cellmark against Sequenom has been dismissed, Sequenom disclosed in a filing with US Securities and Exchange Commission today.

Sequenom said that on June 22, the parties filed a stipulation of dismissal with the US District Court for the Southern District of California in which the claims made by Beckman and Orchid were dismissed, as were the counterclaims by Sequenom. The parties agreed to bear their own attorneys' fees and costs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.